Clinical Trials
3
Active:1
Completed:2
Trial Phases
1 Phases
Not Applicable:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Not Applicable
1 (100.0%)Vivatmo proTM EU-study: FeNO Monitoring in Asthmatic Patients Responding to ICS Treatment
Active, not recruiting
- Conditions
- Asthma
- First Posted Date
- 2022-09-23
- Last Posted Date
- 2022-09-23
- Lead Sponsor
- Bosch Healthcare Solutions GmbH
- Target Recruit Count
- 48
- Registration Number
- NCT05553379
- Locations
- 🇨🇿
MUDr. Ingeborg Vokálova s.r.o, Kralupy Nad Vltavou, Czechia
🇨🇿Alergologie Skopkova, s.r.o, Ostrava, Czechia
🇨🇿Plicní středisko Teplice s.r.o, Teplice, Czechia
Vivatmo Pro™ for Fractional Exhaled Nitric Oxide (FeNO) Monitoring in U.S. Asthmatic Patients
Not Applicable
Completed
- Conditions
- Asthma in ChildrenAsthma
- First Posted Date
- 2020-06-29
- Last Posted Date
- 2022-06-06
- Lead Sponsor
- Bosch Healthcare Solutions GmbH
- Target Recruit Count
- 122
- Registration Number
- NCT04450108
- Locations
- 🇺🇸
Clinical Research Center of Alabama, Birmingham, Alabama, United States
🇺🇸Kern Research, Inc., Bakersfield, California, United States
🇺🇸Chesapeake Clinical Research, Inc., White Marsh, Maryland, United States
News
No news found